Skip Navigation U.S. Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
Archive print banner
National Healthcare Disparities Report, 2006

Effectiveness of Care: HIV and AIDS

This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.

Please go to www.ahrq.gov for current information.


AIDS Prevention
New AIDS cases per 100,000 population age 13+
Management of HIV/AIDS
HIV-infection deaths per 100,000 population
HIV patients with CD4 counts less than 200 who received PCP prophylaxis
HIV patients with CD4 counts less than 50 who received MAC prophylaxis


AIDS Prevention

Measure Title

New AIDS cases per 100,000 population age 13 and over.

Measure Source

Healthy People 2010, measure 13-1.

Table

57. New AIDS cases per 100,000 population age 13 and over, United States, 2004, by

  • Ethnicity

Data Source

Centers for Disease Control, National HIV/AIDS Surveillance System.

Denominator

U.S. resident population: adolescents and adults age 13 and over.

Numerator

Number of reported new AIDS cases among adolescents and adults age 13 and over.

Comments

The AIDS case definition used by the HIV/AIDS Surveillance System for an AIDS case is provided by the CDC. Data are adjusted for reporting delay.

CDC Adult HIV/AIDS Confidential Case Report, Form 50.42A, Rev. 7/93

Top of Page


Management of HIV/AIDS

Measure Title

HIV-infection deaths per 100,000 population.

Measure Source

Healthy People 2010, measure 13-14.

Tables

58. HIV-infection deaths per 100,000 population, United States, 2003, by

  • Race
  • Ethnicity
  • Education

Data Source

Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System—Mortality.

Denominator

U.S. resident population.

Numerator

Number of deaths due to HIV infection (ICD-10-CM codes B20-B24).

Comments

Data are age adjusted to the 2000 standard population. Age-adjusted rates are weighted sums of age-specific rates. Resident death data are based on information from death certificates filed in the 50 States and the District of Columbia.

Top of Page


Management of HIV/AIDS

Measure Title

HIV patients with CD4 counts less than 200 who received Pneumocystis jiroveci pneumonia (PCP) prophylaxis.

Measure Source

The HIV Research Network.

Table

59. HIV patients age 18 and over with CD4 cell count less than 200 who received PCP prophylaxis, United States, 2003, by

  • Race

Data Source

HIV Research Network, sponsored by multiple Federal agencies: the Agency for Healthcare Research and Quality (AHRQ), the Center for Substance Abuse Treatment in the Substance Abuse and Mental Health Services Administration (SAMHSA), the HIV/AIDS Bureau in the Health Resources and Services Administration (HRSA), and the Office of AIDS Research in the Office of the Director of the National Institutes of Health (OAR/NIH).

Denominator

Patients diagnosed with HIV with CD4 counts < 200 cells/mm.

Numerator

Subset of denominator who received PCP prophylactic therapy.

Comments

The taxonomy of the PCP organism has been changed; Pneumocystis jiroveci refers to the distinct species that infects humans. The abbreviation PCP is still used to designate Pneumocystis pneumonia.

For further information see Centers for Disease Control and Prevention. Treating opportunistic infections among HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America. MMWR 2004; 53 (No. RR-15): available from the CDC Web site at http://www.cdc.gov/mmwr/.

Top of Page


Management of HIV/AIDS

Measure Title

HIV patients with CD4 counts less than 50 who received Mycobacterium avium complex (MAC) prophylaxis.

Measure Source

The HIV Research Network.

Table

60. HIV patients age 18 and over with CD4 cell count less than 50 who received MAC prophylaxis, United States, 2003, by

  • Race

Data Source

HIV Research Network, sponsored by multiple Federal agencies: the Agency for Healthcare Research and Quality (AHRQ), the Center for Substance Abuse Treatment in the Substance Abuse and Mental Health Services Administration (SAMHSA), the HIV/AIDS Bureau in the Health Resources and Services Administration (HRSA), and the Office of AIDS Research in the Office of the Director of the National Institutes of Health (OAR/NIH).

Denominator

Patients diagnosed with HIV with CD4 counts < 50 cells/mm.

Numerator

Subset of denominator who received MAC prophylactic therapy.

Comments

For further information see Centers for Disease Control and Prevention. Treating opportunistic infections among HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America. MMWR 2004; 53 (No. RR-15): available from the CDC Web site at http://www.cdc.gov/mmwr/.

Top of Page
Return to Appendix Contents

 

The information on this page is archived and provided for reference purposes only.

 

AHRQ Advancing Excellence in Health Care